Sodium Valproate-Induced Gingival Enlargement in a Pediatric Patient: A Case Report With Surgical Intervention
- PMID: 40698209
- PMCID: PMC12281469
- DOI: 10.7759/cureus.86519
Sodium Valproate-Induced Gingival Enlargement in a Pediatric Patient: A Case Report With Surgical Intervention
Abstract
Gingival enlargement occurs secondary to the usage of anti-epileptics. The severity of overgrowth varies among different classes of drugs, with phenytoin having the highest incidence of reported cases, whereas cases associated with sodium valproate are minimal. Factors like drug dose, genetic factors, plaque, gingival inflammation, and periodontal health influence the degree of overgrowth. This case report presents one of the first surgically managed cases of generalized gingival enlargement in a pediatric patient due to chronic usage of sodium valproate.
Keywords: gingival overgrowth; gingivectomy; oral hygiene; plaque; sodium valproate.
Copyright © 2025, Varghese et al.
Conflict of interest statement
Human subjects: Informed consent for treatment and open access publication was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Figures







Similar articles
-
Voclosporin-induced gingival enlargement: A case report.Clin Adv Periodontics. 2025 Jun 26. doi: 10.1002/cap.10369. Online ahead of print. Clin Adv Periodontics. 2025. PMID: 40569085
-
Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.Cochrane Database Syst Rev. 2022 Apr 1;4(4):CD011412. doi: 10.1002/14651858.CD011412.pub4. Cochrane Database Syst Rev. 2022. PMID: 35363878 Free PMC article.
-
Comparison of two treatment modalities in the management of gingival enlargement during orthodontic treatment: a randomized clinical trial.Quintessence Int. 2025 Mar 18;56(3):226-235. doi: 10.3290/j.qi.b5809024. Quintessence Int. 2025. PMID: 39485147 Clinical Trial.
-
Chlorhexidine mouthrinse as an adjunctive treatment for gingival health.Cochrane Database Syst Rev. 2017 Mar 31;3(3):CD008676. doi: 10.1002/14651858.CD008676.pub2. Cochrane Database Syst Rev. 2017. PMID: 28362061 Free PMC article.
-
Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.Cochrane Database Syst Rev. 2017 Dec 15;12(12):CD011412. doi: 10.1002/14651858.CD011412.pub3. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2022 Apr 1;4:CD011412. doi: 10.1002/14651858.CD011412.pub4. PMID: 29243813 Free PMC article. Updated.
References
-
- Dental plaque-induced gingival conditions. Murakami S, Mealey BL, Mariotti A, Chapple IL. J Clin Periodontol. 2018;45 Suppl 20:0–27. - PubMed
-
- Hyperplasia of the gingivae associated with dilantin (sodium diphenyl hydantoinate) therapy. Glickman I, Lewitus MP. J Am Dent Assoc. 1941;1:199–207.
-
- Informational paper: drug-associated gingival enlargement. Dongari-Bagtzoglou A. J Periodontol. 2004;75:1424–1431. - PubMed
-
- Tungare S, Paranjpe AG. YMT Dental College, Navi Mumbai [Internet. Treasure Island (FL): StatPearls Publishing; 2019. Drug-Induced Gingival Overgrowth. - PubMed
Publication types
LinkOut - more resources
Full Text Sources